+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nucleic Acid Isolation and Purification Market Size, Share & Trends Analysis Report by Product, by Type (DNA, RNA), by Application, by Method (Magnetic Bead, Reagent), by End Use, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4661547
  • Report
  • February 2020
  • Region: Global
  • 175 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam plc
  • Beckman Coulter, Inc.
  • Epicentre
  • Illumina, Inc.
  • New England Biolabs
  • Promega Corporation
  • MORE
The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period according to this report. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.

Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.

The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.

Further key findings from the report suggest:
  • The instruments segment is expected to grow at a lucrative pace due to the advent of automated extraction systems resulting in high performance and lower cost for DNA extraction
  • DNA isolation methods accounted for the largest revenue share and are anticipated to witness the fastest progress rate due to ongoing discoveries of simple, rapid, and inexpensive methods
  • The high adoption rate of magnetic bead methods is attributive to its largest revenue share
  • This is because the method can isolate nucleic acids directly from the crude sample without much processing
  • This method is also expected to witness the fastest CAGR owing to the development of functionalized magnetic particles that have been incorporated in buffer systems to provide rapid and efficient extraction
  • Oncology application is projected to witness a lucrative growth rate as liquid biopsy techniques and patient-tailored therapies are gaining traction for cancer diagnosis
  • Hospitals and diagnostic centers accounted for the largest share in 2019, in terms of revenue
  • The high incidence rate of genetic and inherited diseases has increased the usage of nucleic acid isolation in early and accurate diagnosis of these conditions in hospitals
  • Better healthcare infrastructure, a substantial number of technology providers, and rapid adoption of NGS has driven the uptake of nucleic acid extraction products in North America at a large scale
  • Asia Pacific is anticipated to exhibit the fastest CAGR over the forecast period owing to significant public and private commitments towards genomics research and precision medicine, thereby prompting the adoption of isolation techniques
  • QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in the nucleic acid isolation and purification market.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcam plc
  • Beckman Coulter, Inc.
  • Epicentre
  • Illumina, Inc.
  • New England Biolabs
  • Promega Corporation
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation

Chapter 2 Executive Summary
2.1 Nucleic Acid Isolation & Purification Market: Market Outlook
2.2 Nucleic Acid Isolation & Purification Market Segmentation & Scope
2.3 Nucleic Acid Isolation & Purification Market: Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping for Method, 2019
3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
3.2.1 Technology trends
3.2.2 Outsourcing & contract manufacturing trends
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
3.3.1.2 Increase in public-private funding on biotechnology and life sciences research
3.3.1.3 Advancements in automation
3.3.1.4 Growth in NGS technologies
3.3.1.5 Growing demand for genetically modified crops and organisms
3.3.2 Market restraint analysis
3.3.2.1 Expensive instruments and consequent low penetration in emerging countries
3.3.2.2 Challenges related to the use of big data and bioinformatics
3.4 Nucleic Acid Isolation & Purification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5 Industry Analysis - Porter’s
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Agreement
3.6.2 Product developments
3.6.3 Merger & acquisition
3.6.4 Collaboration & partnership

Chapter 4 Nucleic Acid Isolation & Purification Market: Product Estimates & Trend Analysis
4.1 Nucleic Acid Isolation & Purification Market: Product Movement Analysis
4.2 Kits & Reagents
4.2.1 Nucleic acid isolation & purification kits & reagents market, 2016 - 2027 (USD Million)
4.3 Instruments
4.3.1 Nucleic acid isolation & purification instruments market, 2016 - 2027 (USD Million)

Chapter 5 Nucleic Acid Isolation & Purification Market: Type Estimates & Trend Analysis
5.1 Nucleic Acid Isolation & Purification Market: Type Movement Analysis
5.2 DNA Isolation & Purification
5.2.1 DNA isolation & purification market, 2016 - 2027 (USD Million)
5.2.2 Genomic DNA isolation & purification
5.2.2.1 Genomic DNA isolation & purification market, 2016 - 2027 (USD Million)
5.2.3 Plasmid DNA isolation & purification
5.2.3.1 Plasmid DNA isolation & purification market, 2016 - 2027 (USD Million)
5.2.4 Viral DNA isolation & purification
5.2.4.1 Viral DNA isolation & purification market, 2016 - 2027 (USD Million)
5.2.5 Other types
5.2.5.1 Other types of DNA isolation & purification market, 2016 - 2027 (USD Million)
5.3 RNA Isolation & Purification
5.3.1 RNA isolation & purification market, 2016 - 2027 (USD Million)
5.3.2 miRNA isolation & purification
5.3.2.1 miRNA isolation & purification market, 2016 - 2027 (USD Million)
5.3.3 mRNA isolation & purification
5.3.3.1 mRNA isolation & purification market, 2016 - 2027 (USD Million)
5.3.4 Total RNA isolation & purification
5.3.4.1 Total RNA isolation & purification market, 2016 - 2027 (USD Million)
5.3.5 Other Types
5.3.5.1 Other types market, 2016 - 2027 (USD Million)

Chapter 6 Nucleic Acid Isolation & Purification Market: Method Estimates & Trend Analysis
6.1 Nucleic Acid Isolation & Purification Market: Method Movement Analysis
6.2 Column Based Isolation & Purification
6.2.1 Column based isolation & purification market, 2016 - 2027 (USD Million)
6.3 Magnetic Bead Based Isolation & Purification
6.3.1 Magnetic bead based isolation & purification market, 2016 - 2027 (USD Million)
6.4 Reagent Based Isolation & Purification
6.4.1 Reagent based isolation & purification market, 2016 - 2027 (USD Million)
6.5 Other Methods
6.5.1 Other methods market, 2016 - 2027 (USD Million)

Chapter 7 Nucleic Acid Isolation & Purification Market: Applications Estimates & Trend Analysis
7.1 Nucleic Acid Isolation & Purification Market: Application Movement Analysis
7.2 Oncology
7.2.1 Oncology medicine market, 2016 - 2027 (USD Million)
7.3 Precision Medicines
7.3.1 Precision medicine market, 2016 - 2027 (USD Million)
7.4 Diagnostics
7.4.1 Diagnostics market, 2016 - 2027 (USD Million)
7.5 Drug Discovery & Development
7.5.1 Drug discovery & development market, 2016 - 2027 (USD Million)
7.6 Agriculture & Animal Research
7.6.1 Agriculture & animal research market, 2016 - 2027 (USD Million)
7.7 Other Applications
7.7.1 Other applications market, 2016 - 2027 (USD Million)

Chapter 8 Nucleic Acid Isolation & Purification Market: End-use Estimates & Trend Analysis
8.1 Nucleic Acid Isolation & Purification Market: End-use Movement Analysis
8.2 Academic Research Institutes
8.2.1 Academic research institutes market, 2016 - 2027 (USD Million)
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Pharmaceutical and biotechnology companies market, 2016 - 2027 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract research organisations market, 2016 - 2027 (USD Million)
8.5 Hospitals and Diagnostic Centers
8.5.1 Hospitals and diagnostic centres market, 2016 - 2027 (USD Million)
8.6 Other End-use
8.6.1 Other end-use market, 2016 - 2027 (USD Million)

Chapter 9 Nucleic Acid Isolation & Purification Market: Regional Estimates & Trend Analysis, by Product, Type, Method, Application, & End-use
9.1 Nucleic Acid Isolation & Purification Market Share by Regions, 2019 & 2027
9.2 North America
9.2.1 North America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.2.2.2 U.S. nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.2.2.3 U.S. nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.2.2.4 U.S. nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.2.2.5 U.S. nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Canada nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.2.3.2 Canada nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.2.3.3 Canada nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.2.3.4 Canada nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.2.3.5 Canada nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.3 Europe
9.3.1 Europe nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
9.3.2 Germany
9.3.2.1 Germany nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.3.2.2 Germany nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.3.2.3 Germany nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.3.2.4 Germany nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.3.2.5 Germany nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.3.3.2 U.K. nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.3.3.3 U.K. nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.3.3.4 U.K. nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.3.3.5 U.K. nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
9.4.2 Japan
9.4.2.1 Japan nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.4.2.2 Japan nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.4.2.3 Japan nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.4.2.4 Japan nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.4.2.5 Japan nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.4.3 China
9.4.3.1 China nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.4.3.2 China nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.4.3.3 China nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.4.3.4 China nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.4.3.5 China nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.5 Latin America
9.5.1 Latin America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.5.2.2 Brazil nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.5.2.3 Brazil nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.5.2.4 Brazil nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.5.2.5 Brazil nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.5.3.2 Mexico nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.5.3.3 Mexico nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.5.3.4 Mexico nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.5.3.5 Mexico nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
9.6 MEA
9.6.1 MEA nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
9.6.2.2 South Africa nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
9.6.2.3 South Africa nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
9.6.2.4 South Africa nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
9.6.2.5 South Africa nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)

Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Recent Developments & Impact Analysis, by Key Market Participants
10.3 Public Companies
10.3.1 Company market position analysis
10.4 Private Companies
10.4.1 List of key emerging companies
10.5 Strategy Framework
10.6 Company Profiles
10.6.1 QIAGEN
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic initiatives
10.6.2 Thermo Fisher Scientific, Inc.
10.6.2.1 Company overview
10.6.2.2 Life Technologies Corporation
10.6.2.2.1 Company overview
10.6.2.3 Financial performance
10.6.2.4 Product benchmarking
10.6.2.5 Strategic initiatives
10.6.3 Illumina, Inc.
10.6.3.1 Company overview
10.6.3.2 Epicentre
10.6.3.2.1 Company overview
10.6.3.3 Financial performance
10.6.3.4 Product benchmarking
10.6.3.5 Strategic initiatives
10.6.4 Danaher
10.6.4.1 Company overview
10.6.4.2 Beckman Coulter, Inc.
10.6.4.2.1 Company overview
10.6.4.3 Financial performance
10.6.4.4 Product benchmarking
10.6.4.5 Strategic initiatives
10.6.5 F. Hoffmann-La Roche Ltd.
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic initiatives
10.6.6 Merck KGaA
10.6.6.1 Company overview
10.6.6.2 Sigma-Aldrich Co. LLC
10.6.6.2.1 Company overview
10.6.6.3 Financial performance
10.6.6.4 Product benchmarking
10.6.6.5 Strategic initiatives
10.6.7 Agilent Technologies, Inc.
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Bio-Rad Laboratories, Inc.
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 GE Healthcare
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 Takara Bio USA Holdings, Inc.
10.6.10.1 Company overview
10.6.10.2 Clontech Laboratories, Inc.
10.6.10.2.1 Company overview
10.6.10.3 Financial performance
10.6.10.4 Product benchmarking
10.6.10.5 Strategic initiatives
10.6.11 Promega Corporation
10.6.11.1 Company overview
10.6.11.2 Financial performance
10.6.11.3 Product benchmarking
10.6.11.4 Strategic initiatives
10.6.12 Norgen Biotek Corp.
10.6.12.1 Company overview
10.6.12.2 Financial performance
10.6.12.3 Product benchmarking
10.6.12.4 Strategic initiatives
10.6.13 New England Biolabs
10.6.13.1 Company overview
10.6.13.2 Financial performance
10.6.13.3 Product benchmarking
10.6.13.4 Strategic initiatives
10.6.14 AUTOGEN INC.
10.6.14.1 Company overview
10.6.14.2 Financial performance
10.6.14.3 Product benchmarking
10.6.14.4 Strategic initiatives
10.6.15 LGC Biosearch Technologies
10.6.15.1 Company overview
10.6.15.2 Financial performance
10.6.15.3 Product benchmarking
10.6.15.4 Strategic initiatives
10.6.16 Biogenuix
10.6.16.1 Company overview
10.6.16.2 Financial performance
10.6.16.3 Product benchmarking
10.6.16.4 Strategic initiatives
10.6.17 PCR Biosystems Inc.
10.6.17.1 Company overview
10.6.17.2 Financial performance
10.6.17.3 Product benchmarking
10.6.17.4 Strategic initiatives
10.6.18 MagGenome
10.6.18.1 Company overview
10.6.18.2 Financial performance
10.6.18.3 Product benchmarking
10.6.18.4 Strategic initiatives
10.6.19 Axon Scientific Sdn. Bhd.
10.6.19.1 Company overview
10.6.19.2 Financial performance
10.6.19.3 Product benchmarking
10.6.19.4 Strategic initiatives
10.6.20 Abcam plc
10.6.20.1 Company overview
10.6.20.2 Financial performance
10.6.20.3 Product benchmarking
10.6.20.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Life Technologies Corporation
  • Illumina, Inc.
  • Epicentre
  • Danaher
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Sigma-Aldrich Co. LLC
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Takara Bio USA Holdings, Inc.
  • Clontech Laboratories, Inc.
  • Promega Corporation
  • Norgen Biotek Corp.
  • New England Biolabs
  • AUTOGEN INC.
  • LGC Biosearch Technologies
  • Biogenuix
  • PCR Biosystems Inc.
  • MagGenome
  • Axon Scientific Sdn. Bhd.
  • Abcam plc
Note: Product cover images may vary from those shown
Adroll
adroll